IL21 and stroke disorder: During the acute phase of ischemic stroke, our lab previously demonstrated that CD4 T cell-produced IL-21 contributes to damage following transient middle cerebral artery occlusion (tMCAO) in mice and postmortem brain tissues from stroke patients contain IL-21+ cells in perivascular regions in the necrotic brain parenchyma [22].